Harold C. Standiford
- Infectious Diseases top 0.5%
- Pharmacology top 0.2%
- Molecular Medicine top 0.2%
- Clinical Biochemistry top 0.2%
- Epidemiology top 2%
- Co-authors
- George L. DrusanoBeverly A. TatemKaren I. PlaisanceDachelle JohnsonAlan ForrestMarc RosenJoan HebdenBruce S. Ribner
- Topics
- Antibiotics Pharmacokinetics and Efficacy (46 papers)Antibiotic Resistance in Bacteria (35 papers)Antimicrobial Resistance in Staphylococcus (27 papers)
- Partner nations
- United StatesIsraelVenezuela
In The Last Decade
Harold C. Standiford
90 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Infectious Diseases 1.6k
- Pharmacology 1.6k
- Molecular Medicine 1.4k
- Clinical Biochemistry 1.2k
- Epidemiology 1.2k
Countries citing papers authored by Harold C. Standiford
This map shows the geographic impact of Harold C. Standiford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harold C. Standiford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harold C. Standiford more than expected).
Fields of papers citing papers by Harold C. Standiford
This network shows the impact of papers produced by Harold C. Standiford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harold C. Standiford. The network helps show where Harold C. Standiford may publish in the future.
Co-authorship network of co-authors of Harold C. Standiford
This figure shows the co-authorship network connecting the top 25 collaborators of Harold C. Standiford. A scholar is included among the top collaborators of Harold C. Standiford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harold C. Standiford. Harold C. Standiford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 170 | |
| 3 | 20 | |
| 4 | 13 | |
| 5 | 58 | |
| 6 | 90 | |
| 7 | 15 | |
| 8 | 12 | |
| 9 | 31 | |
| 10 | 5 | |
| 11 | Methicillin-resistant Staphylococcus aureus: A consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and managementbreakdown → | 542 |
| 12 | 227 | |
| 13 | Characterization of enterococcal strains exhibiting a novel glycopeptide susceptibility pattern | 1 |
| 14 | 42 | |
| 15 | 9 | |
| 16 | 26 | |
| 17 | 13 | |
| 18 | 10 | |
| 19 | 32 | |
| 20 | 33 |
About Harold C. Standiford
Harold C. Standiford is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Clinical Biochemistry, having authored 92 papers that have together received 4.5k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (46 papers), Antibiotic Resistance in Bacteria (35 papers) and Antimicrobial Resistance in Staphylococcus (27 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (668 citations), Molecular Medicine (1.4k citations) and Clinical Biochemistry (1.2k citations). Harold C. Standiford has collaborated with scholars based in United States, Israel and Venezuela. Frequent co-authors include George L. Drusano, Beverly A. Tatem, Karen I. Plaisance, Dachelle Johnson, Alan Forrest, Marc Rosen, Joan Hebden, Bruce S. Ribner, Maury E. Mulligan and Joseph F. John. Their work appears in journals such as JAMA, Clinical Infectious Diseases and The American Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.